Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Optimizing Body Mass Index (BMI) With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy

Trial Profile

Optimizing Body Mass Index (BMI) With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 May 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs TCMCB 07 (Primary)
  • Indications Cachexia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms Paradox
  • Sponsors Endevica Bio

Most Recent Events

  • 17 Apr 2025 According to the Endevica Bio Media Release, The first patient has been dosed in the study. And, The trial, is being conducted in partnership with WuXi Clinical.
  • 17 Apr 2025 Status changed from not yet recruiting to recruiting.
  • 26 Dec 2024 New trial record

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top